Recommended Talks:

eAccess Meetings: 2016 Keystone Symposia on HIV Vaccines
Ending the HIV/AIDS Pandemic: Follow the Science
November 2016
Anthony Fauci, NIAID, NIH
eAccess Meetings: 2016 Keystone Symposia on HIV Vaccines
A broadly neutralizing antibody from an elite neutralizer targets a novel site at the gp120-gp41 interface
November 2016
Marit J van Gils, University of Amsterdam
eAccess Meetings: 2016 Keystone Symposia on HIV Vaccines
A novel conserved-region T-cell mosaic vaccine with very high global coverage of HIV-1 variants is recognized by protective responses in chronic untreated infection
November 2016
Tomas Hanke, University of Oxford
Nucleic Acid Delivery Devices for HIV Vaccines
Exploring mechanisms of microneedle vaccine delivery to skin
May 2015
Linda Klavinskis, Kings College London
HIV Envelope Protein Manufacturing
Production of HIV ENV protein for P5 Clinical Studies
June 2015
Fred Porter, GSK Vaccines

Search:

Search term(s):

Search for text in:

separate each search
term with a space

Multiple terms:

Conference Years:

Content Type:

Latest Additions

Meeting Format: 2 hour meeting   |   July 2015
An interactive session at IAS 2015 to explore the rapidly evolving HIV vaccine field, ranging from vaccine design to development and testing. Webcasts | Learn More
Meeting Format: 2 day meeting   |   June 2015
An exchange of information and experiences and a status update of ongoing efforts related to the GMP manufacturing of HIV ENV proteins. Webcasts | Learn More
Meeting Format: 2 hour webinar   |   May 2015
A focus on immunogens design, novel immunization regimens, and tracking of antibody responses with the goal of eliciting broadly neutralizing antibodies. Webcasts | Learn More
Meeting Format: 1 day meeting   |   May 2015
Review the landscape of past, current and future nucleic acid delivery technologies and learn from the experience of representative clinical trials. Webcasts | Learn More
Meeting Format: 2 hour webinar   |   September 2014
Review the potential roles of the complement system in modulating humoral immunity and discuss the potential to advance the field in a new direction. Webcasts | Learn More
Meeting Format: 1 hour webinar   |   November 2013
A consultation to help determine the intersection between therapeutic and preventive vaccines and to provide recommendations for future developments. Webcasts | Learn More
Meeting Format: 1 hour webinar   |   September 2013
Immunologists and vaccine developers from industry, academia, and government agencies address the challenges of developing a durable HIV vaccine. Webcasts | Learn More
Meeting Format: 1 hour webinar   |   May 2013
A review of current research efforts and remaining gaps and needs in addressing Vaccine-Induced Sero-Positivity/Sero-Reactivity. Webcasts | Learn More
1 2